Asian Penny Stocks To Watch In September 2025

As global markets respond to the Federal Reserve’s recent interest rate cut, attention has turned to Asia where economic signals are mixed, with China’s slowdown contrasting Japan’s hawkish monetary stance. In this context, penny stocks—often representing smaller or newer companies—remain a relevant investment area due to their potential for growth and affordability. While the term “penny stocks” might seem outdated, these investments can still offer significant opportunities when backed by strong financials and market conditions that favor smaller-capitalization stocks.

Top 10 Penny Stocks In AsiaNameShare PriceMarket CapRewards & RisksFood Moments (SET:FM)THB3.92THB3.87B✅ 4 ⚠️ 0 View Analysis >JBM (Healthcare) (SEHK:2161)HK$3.09HK$2.52B✅ 3 ⚠️ 1 View Analysis >Lever Style (SEHK:1346)HK$1.57HK$971.08M✅ 4 ⚠️ 1 View Analysis >TK Group (Holdings) (SEHK:2283)HK$2.43HK$2.02B✅ 4 ⚠️ 1 View Analysis >CNMC Goldmine Holdings (Catalist:5TP)SGD0.925SGD374.89M✅ 4 ⚠️ 1 View Analysis >T.A.C. Consumer (SET:TACC)THB4.84THB2.9B✅ 3 ⚠️ 3 View Analysis >Yangzijiang Shipbuilding (Holdings) (SGX:BS6)SGD3.30SGD12.99B✅ 5 ⚠️ 1 View Analysis >Ekarat Engineering (SET:AKR)THB0.97THB1.43B✅ 2 ⚠️ 2 View Analysis >Livestock Improvement (NZSE:LIC)NZ$0.95NZ$135.23M✅ 2 ⚠️ 5 View Analysis >Rojana Industrial Park (SET:ROJNA)THB4.92THB9.94B✅ 3 ⚠️ 3 View Analysis >

Click here to see the full list of 982 stocks from our Asian Penny Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Inter Pharma Public Company Limited operates in Thailand, focusing on the manufacturing, importing, and distribution of drug and dietary supplement products for both humans and animals, with a market cap of approximately THB2.54 billion.

Operations: The company’s revenue is primarily derived from Human Healthcare at THB1.51 billion, followed by Animal Healthcare at THB306.42 million, and Hospital and clinics contributing THB216.93 million.

Market Cap: THB2.54B

Inter Pharma Public Company Limited has shown significant improvement in its financial performance, with recent earnings growth of 254.1% over the past year, outpacing the industry average. The company’s revenue for the second quarter was THB540.78 million, up from THB448.14 million a year ago, reflecting a solid increase in net income to THB28.22 million from THB3.42 million previously. Despite low return on equity at 3.7%, Inter Pharma’s debt management appears satisfactory with a net debt to equity ratio of 2.7%. Short-term assets exceed both short and long-term liabilities, indicating strong liquidity positions amidst stable weekly volatility.

SET:IP Financial Position Analysis as at Sep 2025

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Thoresen Thai Agencies Public Company Limited, with a market cap of THB8.95 billion, operates as a shipping company across Asia, Africa, the United States, Europe, and Oceania through its subsidiaries.

Operations: The company’s revenue segments consist of Shipping (THB6.67 billion), Agrochemical (THB3.98 billion), Offshore Service (THB16.91 billion), and Food and Beverage (THB2.25 billion).

Market Cap: THB8.95B

Thoresen Thai Agencies has faced challenges with declining earnings, reporting a net income drop to THB90.11 million in the second quarter from THB438.2 million a year prior, and revenue decreased to THB7.23 billion from THB9.54 billion. Despite these setbacks, the company maintains a solid liquidity position with short-term assets exceeding liabilities and manageable debt levels supported by operating cash flow coverage of 27.3%. The recent share buyback program, aimed at enhancing return on equity and earnings per share, reflects strategic efforts to bolster shareholder value amidst fluctuating profit margins and stable weekly volatility.

SET:TTA Financial Position Analysis as at Sep 2025

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Sanlux Co.,Ltd specializes in the research, development, production, and sales of rubber V-belts both in China and internationally, with a market cap of CN¥4.18 billion.

Operations: The company’s revenue is primarily derived from the construction industry, totaling CN¥941.93 million.

Market Cap: CN¥4.18B

Sanlux Co., Ltd, with a market cap of CN¥4.18 billion, primarily generates revenue from the construction sector totaling CN¥941.93 million. Despite declining earnings at an annual rate of 28.6% over five years and negative growth last year, the company maintains financial stability with short-term assets exceeding both short and long-term liabilities. Debt levels have decreased over time, supported by operating cash flow covering 23% of debt and more cash than total debt on hand. However, profitability challenges persist with a low return on equity of 1.4% and reduced net profit margins impacted by significant one-off losses recently reported.

SZSE:002224 Financial Position Analysis as at Sep 2025Summing It All Up

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com